Cambridge Investment Research Advisors’s Fidelity Enhanced U.S. All-Cap Equity ETF FEAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Sell
16,645
-9,814
-37% -$305K ﹤0.01% 2890
2026
Q1
$736K Sell
26,459
-24,118
-48% -$699K ﹤0.01% 2449
2025
Q4
$1.47M Sell
50,577
-19,015
-27% -$545K ﹤0.01% 1792
2025
Q3
$1.97M Buy
+69,592
New +$1.89M 0.01% 1521

Other funds holding FEAC

Cambridge Investment Research Advisors's FEAC Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Fidelity Enhanced U.S. All-Cap Equity ETF (FEAC) stake by 37% in Q2 2026, selling an estimated $305K and leaving 16,645 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

Cambridge Investment Research Advisors first reported a position in FEAC in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.97M in Q3 2025. 4 funds tracked by Wall St. Rank hold FEAC as of Q2 2026.

  • Cambridge Investment Research Advisors held 16,645 shares of Fidelity Enhanced U.S. All-Cap Equity ETF worth $538K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 9,814 Fidelity Enhanced U.S. All-Cap Equity ETF shares in Q2 2026, an estimated $305K.
  • Fidelity Enhanced U.S. All-Cap Equity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2890 holding.
  • Cambridge Investment Research Advisors first reported a position in Fidelity Enhanced U.S. All-Cap Equity ETF in Q3 2025 and has held it in 4 quarters since.
  • Cambridge Investment Research Advisors's Fidelity Enhanced U.S. All-Cap Equity ETF position peaked at $1.97M in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Fidelity Enhanced U.S. All-Cap Equity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.